


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+6.87%
+0.83%
+1.37%
+5.22%
+2.26%
ZBH
Zimmer Biomet
$93.62
Strengths

Earnings are forecast to grow
Risk Analysis

Investors losing their confidence
Chart
$101.14 (-7.44%)
$105.01 (-10.85%)
$93.67 (-0.05%)
$106.91 (-12.43%)
ZBH has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

ZBH overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Earnings decline YoY
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow
![]()
ZBH Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ZBH Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is ZBH current stock price?
What are ZBH stock strengths?
What is ZBH Risk Level?
What is ZBH market cap and volume?
What is ZBH current Stock IQ?
Should I buy ZBH stock right now?
Is ZBH a Strong Buy right now?
What does a 'Strong Buy' rating mean for ZBH?
What does a 'Strong Sell' rating mean for ZBH?
What factors influence ZBH's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+6.87%
+0.83%
+1.37%
+5.22%
+2.26%
ZBH
Zimmer Biomet
Current Price
$93.62
Stock Insights
Strengths

Earnings are forecast to grow
Risk Analysis

Investors losing their confidence

Chart
$101.14 (-7.44%)
$105.01 (-10.85%)
$93.67 (-0.05%)
$106.91 (-12.43%)
ZBH Analysts Opinion
ZBH Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Earnings decline YoY
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow
![]()
ZBH Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ZBH Street Sentiment is bullish and have positive views on the near-term outlook
ZBH has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels.
ZBH Latest Analysis
Zimmer Biomet Holdings (ZBH) Faces Investor Scrutiny Amid Emerging Markets Distributor Orders Cancelation Reduced Top-Line Revenue Forecast -- Hagens Berman. SAN FRANCISCO Nov. 18 2025 /PRNewswire/ -- On November 5 2025 investors in Zimmer Biomet Holdings Inc. (NYSE: ZBH) saw the price of their shares tumble $15.63 (-15%) after the company announced its Q3 2025 financial results and revealed cancelation of emerging markets distributor...
Tue Nov 18, 2025
Zimmer Biomet Holdings Inc. (ZBH) Presents at Jefferies London Healthcare Conference 2025 Transcript.
Tue Nov 18, 2025
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.
Fri Nov 14, 2025
Zimmer Biomet Announces FDA Clearance For Enhanced Version Of ROSA Knee System . (RTTNews) - Zimmer Biomet Holdings Inc. (ZBH) announced FDA 510(k) clearance of ROSA Knee with OptimiZe an enhanced version of its ROSA Knee System. Zimmer Biomet will conduct a targeted release of ROSA Knee with OptimiZe later in the current year with commercial availability i
Fri Nov 14, 2025
Zimmer Biomet Receives United States FDA Clearance for Enhanced Version of ROSA® Knee Robotic Technology. ROSA ® Knee with OptimiZe ™ Offers Personalized Surgical Planning and Drives Confidence in Delivering Accurate and Reproducible Outcomes1 WARSAW Ind. Nov. 14 2025 /PRNewswire/ -- Zimmer Biomet Holdings Inc. (NYSE and SIX: ZBH) a global medical technology leader today announced United States...
Fri Nov 14, 2025
Zimmer Biomet price target lowered to $93 from $101 at Canaccord.
Tue Nov 11, 2025
UBS Maintains Zimmer Biomet Holdings (ZBH) Sell Recommendation. Fintel reports that on November 6 2025 UBS maintained coverage of Zimmer Biomet Holdings (NYSE:ZBH) with a Sell recommendation. Analyst Price Forecast Suggests 28.79% Upside
Fri Nov 7, 2025
Zimmer Biomet (ZBH) Gives Up 15% on Weak Q3. We recently published 10 Stocks Left Behind Amid Wall Street Cheer. Zimmer Biomet Holdings Inc. (NYSE:ZBH) is one of the worst-performing stocks on Wednesday. Zimmer dropped its share prices by 15.15 percent on Wednesday to end at $87.55 apiece as investors soured on its organic sales growth forecast amid weakness in international markets alongside a [….]
Thu Nov 6, 2025
Zimmer Biomet Holdings Inc. (NYSE:ZBH) Q3 2025 Earnings Call Transcript. Zimmer Biomet Holdings Inc. (NYSE:ZBH) Q3 2025 Earnings Call Transcript November 5 2025 Zimmer Biomet Holdings Inc. misses on earnings expectations. Reported EPS is $1.16 EPS expectations were $1.88. Operator: Good morning ladies and gentlemen and welcome to the Zimmer Biomet Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder this conference is [….]
Thu Nov 6, 2025
This Zimmer Biomet Analyst Is No Longer ish. Here Are Top 5 Downgrades For Thursday. Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes including upgrades downgrades and initiations please see our analyst ratings page.Morgan Stanley analyst Erik Woodring downgradedKRNT) from Overweight to Equal-Weight and lowered the price target from $20 to $15. Kornit Digital shares closed at $12.50 on Wednesday. See how other analysts view this
Thu Nov 6, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.